The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

The Atrial Flow Regulator device: expanding the field of interatrial shunting for treating heart failure patients

EuroIntervention 2019;15:398-400. DOI: 10.4244/EIJV15I5A73

1. Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada


Despite decades of major advances in the treatment of patients with heart failure (HF), morbidity and mortality remain high regardless of aetiology. Increased left atrial pressure (LAP) leading to pulmonary congestion is the main mechanism precipitating acute decompensation and the worsening of symptoms. Implantable haemodynamic pressure monitoring has been shown to decrease HF hospitalisation and improve outcomes by guiding dose titration of drugs impacting on LAP1. Despite the benefits of device-guided therapy, it should be noted that most HF patients are elderly and exhibit multiple comorbidities which may represent a challenge for both medication self-titration and close follow-up. The ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Working across borders: EAPCI and the National Societies